nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—JUN—epilepsy syndrome	0.283	0.836	CbGaD
Irbesartan—UGT1A3—Lamotrigine—epilepsy syndrome	0.0651	0.165	CbGbCtD
Irbesartan—CYP2D6—epilepsy syndrome	0.0556	0.164	CbGaD
Irbesartan—UGT1A3—Valproic Acid—epilepsy syndrome	0.0335	0.0849	CbGbCtD
Irbesartan—CYP2C8—Trimethadione—epilepsy syndrome	0.0152	0.0385	CbGbCtD
Irbesartan—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0143	0.0362	CbGbCtD
Irbesartan—PTGS1—Diazepam—epilepsy syndrome	0.0135	0.0342	CbGbCtD
Irbesartan—PTGS1—Valproic Acid—epilepsy syndrome	0.0106	0.0269	CbGbCtD
Irbesartan—CYP2C9—Trimethadione—epilepsy syndrome	0.0106	0.0269	CbGbCtD
Irbesartan—CYP2C8—Carbamazepine—epilepsy syndrome	0.0103	0.026	CbGbCtD
Irbesartan—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00996	0.0253	CbGbCtD
Irbesartan—CYP2C8—Primidone—epilepsy syndrome	0.00957	0.0243	CbGbCtD
Irbesartan—CYP2C8—Phenytoin—epilepsy syndrome	0.0092	0.0233	CbGbCtD
Irbesartan—CYP2C8—Propofol—epilepsy syndrome	0.00858	0.0218	CbGbCtD
Irbesartan—CYP2C8—Phenobarbital—epilepsy syndrome	0.0082	0.0208	CbGbCtD
Irbesartan—CYP1A2—Carbamazepine—epilepsy syndrome	0.00794	0.0202	CbGbCtD
Irbesartan—CYP2C8—Diazepam—epilepsy syndrome	0.00777	0.0197	CbGbCtD
Irbesartan—CYP1A2—Primidone—epilepsy syndrome	0.00741	0.0188	CbGbCtD
Irbesartan—CYP2C9—Carbamazepine—epilepsy syndrome	0.00715	0.0182	CbGbCtD
Irbesartan—CYP2C9—Primidone—epilepsy syndrome	0.00668	0.017	CbGbCtD
Irbesartan—CYP1A2—Propofol—epilepsy syndrome	0.00664	0.0169	CbGbCtD
Irbesartan—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00662	0.0168	CbGbCtD
Irbesartan—CYP2C9—Phenytoin—epilepsy syndrome	0.00642	0.0163	CbGbCtD
Irbesartan—CYP1A2—Phenobarbital—epilepsy syndrome	0.00635	0.0161	CbGbCtD
Irbesartan—CYP3A4—Felbamate—epilepsy syndrome	0.00616	0.0156	CbGbCtD
Irbesartan—CYP3A4—Trimethadione—epilepsy syndrome	0.00616	0.0156	CbGbCtD
Irbesartan—CYP2C8—Valproic Acid—epilepsy syndrome	0.00613	0.0156	CbGbCtD
Irbesartan—CYP1A2—Diazepam—epilepsy syndrome	0.00602	0.0153	CbGbCtD
Irbesartan—CYP2C9—Propofol—epilepsy syndrome	0.00598	0.0152	CbGbCtD
Irbesartan—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00579	0.0147	CbGbCtD
Irbesartan—CYP2C9—Phenobarbital—epilepsy syndrome	0.00572	0.0145	CbGbCtD
Irbesartan—CYP2D6—Propofol—epilepsy syndrome	0.00547	0.0139	CbGbCtD
Irbesartan—CYP2C9—Diazepam—epilepsy syndrome	0.00542	0.0138	CbGbCtD
Irbesartan—CYP3A4—Clonazepam—epilepsy syndrome	0.00524	0.0133	CbGbCtD
Irbesartan—CYP3A4—Clobazam—epilepsy syndrome	0.00502	0.0127	CbGbCtD
Irbesartan—CYP1A2—Valproic Acid—epilepsy syndrome	0.00474	0.012	CbGbCtD
Irbesartan—CYP2C9—Valproic Acid—epilepsy syndrome	0.00427	0.0108	CbGbCtD
Irbesartan—CYP3A4—Rufinamide—epilepsy syndrome	0.00427	0.0108	CbGbCtD
Irbesartan—CYP3A4—Carbamazepine—epilepsy syndrome	0.00416	0.0106	CbGbCtD
Irbesartan—CYP3A4—Primidone—epilepsy syndrome	0.00388	0.00986	CbGbCtD
Irbesartan—CYP3A4—Phenytoin—epilepsy syndrome	0.00373	0.00947	CbGbCtD
Irbesartan—CYP3A4—Propofol—epilepsy syndrome	0.00348	0.00883	CbGbCtD
Irbesartan—CYP3A4—Acetazolamide—epilepsy syndrome	0.00333	0.00844	CbGbCtD
Irbesartan—CYP3A4—Phenobarbital—epilepsy syndrome	0.00333	0.00844	CbGbCtD
Irbesartan—CYP3A4—Midazolam—epilepsy syndrome	0.00328	0.00832	CbGbCtD
Irbesartan—CYP3A4—Diazepam—epilepsy syndrome	0.00315	0.008	CbGbCtD
Irbesartan—CYP3A4—Zonisamide—epilepsy syndrome	0.00308	0.00781	CbGbCtD
Irbesartan—CYP3A4—Valproic Acid—epilepsy syndrome	0.00248	0.00631	CbGbCtD
Irbesartan—CYP3A4—Topiramate—epilepsy syndrome	0.00224	0.00569	CbGbCtD
Irbesartan—JUN—ganglion—epilepsy syndrome	0.00167	0.112	CbGeAlD
Irbesartan—JUN—hindbrain—epilepsy syndrome	0.00127	0.0848	CbGeAlD
Irbesartan—JUN—brainstem—epilepsy syndrome	0.000727	0.0486	CbGeAlD
Irbesartan—JUN—forebrain—epilepsy syndrome	0.000702	0.0469	CbGeAlD
Irbesartan—JUN—telencephalon—epilepsy syndrome	0.000646	0.0431	CbGeAlD
Irbesartan—EDNRA—medulla oblongata—epilepsy syndrome	0.000556	0.0371	CbGeAlD
Irbesartan—PTGS1—ganglion—epilepsy syndrome	0.000554	0.037	CbGeAlD
Irbesartan—AGTR1—forebrain—epilepsy syndrome	0.000529	0.0353	CbGeAlD
Irbesartan—EDNRA—midbrain—epilepsy syndrome	0.000508	0.0339	CbGeAlD
Irbesartan—JUN—medulla oblongata—epilepsy syndrome	0.000507	0.0339	CbGeAlD
Irbesartan—JUN—midbrain—epilepsy syndrome	0.000464	0.031	CbGeAlD
Irbesartan—JUN—spinal cord—epilepsy syndrome	0.000452	0.0302	CbGeAlD
Irbesartan—Olmesartan—ABCC2—epilepsy syndrome	0.000452	0.415	CrCbGaD
Irbesartan—JUN—head—epilepsy syndrome	0.000402	0.0268	CbGeAlD
Irbesartan—AGTR1—medulla oblongata—epilepsy syndrome	0.000382	0.0255	CbGeAlD
Irbesartan—JUN—nervous system—epilepsy syndrome	0.000381	0.0255	CbGeAlD
Irbesartan—JUN—central nervous system—epilepsy syndrome	0.000367	0.0245	CbGeAlD
Irbesartan—JUN—cerebellum—epilepsy syndrome	0.000359	0.024	CbGeAlD
Irbesartan—CYP2D6—hindbrain—epilepsy syndrome	0.000345	0.0231	CbGeAlD
Irbesartan—EDNRA—brain—epilepsy syndrome	0.000319	0.0213	CbGeAlD
Irbesartan—AGTR1—head—epilepsy syndrome	0.000303	0.0202	CbGeAlD
Irbesartan—JUN—brain—epilepsy syndrome	0.000291	0.0195	CbGeAlD
Irbesartan—AGTR1—nervous system—epilepsy syndrome	0.000287	0.0192	CbGeAlD
Irbesartan—AGTR1—central nervous system—epilepsy syndrome	0.000276	0.0185	CbGeAlD
Irbesartan—PTGS1—forebrain—epilepsy syndrome	0.000232	0.0155	CbGeAlD
Irbesartan—AGTR1—brain—epilepsy syndrome	0.000219	0.0146	CbGeAlD
Irbesartan—PTGS1—telencephalon—epilepsy syndrome	0.000214	0.0143	CbGeAlD
Irbesartan—CYP2D6—brainstem—epilepsy syndrome	0.000198	0.0132	CbGeAlD
Irbesartan—CYP2D6—forebrain—epilepsy syndrome	0.000191	0.0128	CbGeAlD
Irbesartan—Valsartan—ALB—epilepsy syndrome	0.000179	0.164	CrCbGaD
Irbesartan—CYP2D6—telencephalon—epilepsy syndrome	0.000176	0.0117	CbGeAlD
Irbesartan—Losartan—CYP2C19—epilepsy syndrome	0.000157	0.145	CrCbGaD
Irbesartan—PTGS1—spinal cord—epilepsy syndrome	0.00015	0.01	CbGeAlD
Irbesartan—PTGS1—head—epilepsy syndrome	0.000133	0.00889	CbGeAlD
Irbesartan—Candesartan—ABCB1—epilepsy syndrome	0.000129	0.119	CrCbGaD
Irbesartan—PTGS1—nervous system—epilepsy syndrome	0.000126	0.00843	CbGeAlD
Irbesartan—PTGS1—central nervous system—epilepsy syndrome	0.000121	0.00811	CbGeAlD
Irbesartan—CYP2C8—brain—epilepsy syndrome	0.000119	0.00794	CbGeAlD
Irbesartan—CYP2D6—head—epilepsy syndrome	0.000109	0.00731	CbGeAlD
Irbesartan—CYP3A4—nervous system—epilepsy syndrome	0.000105	0.00704	CbGeAlD
Irbesartan—CYP2D6—nervous system—epilepsy syndrome	0.000104	0.00693	CbGeAlD
Irbesartan—CYP3A4—central nervous system—epilepsy syndrome	0.000101	0.00678	CbGeAlD
Irbesartan—CYP2D6—central nervous system—epilepsy syndrome	9.98e-05	0.00667	CbGeAlD
Irbesartan—CYP2D6—cerebellum—epilepsy syndrome	9.76e-05	0.00652	CbGeAlD
Irbesartan—PTGS1—brain—epilepsy syndrome	9.64e-05	0.00644	CbGeAlD
Irbesartan—Losartan—ALB—epilepsy syndrome	8.72e-05	0.0803	CrCbGaD
Irbesartan—Losartan—ABCB1—epilepsy syndrome	8.33e-05	0.0766	CrCbGaD
Irbesartan—CYP2D6—brain—epilepsy syndrome	7.93e-05	0.00529	CbGeAlD
Irbesartan—Anorexia—Valproic Acid—epilepsy syndrome	3.2e-05	0.000202	CcSEcCtD
Irbesartan—Tremor—Gabapentin—epilepsy syndrome	3.19e-05	0.000202	CcSEcCtD
Irbesartan—Rash—Diazepam—epilepsy syndrome	3.18e-05	0.000201	CcSEcCtD
Irbesartan—Dermatitis—Diazepam—epilepsy syndrome	3.18e-05	0.000201	CcSEcCtD
Irbesartan—Visual impairment—Topiramate—epilepsy syndrome	3.18e-05	0.000201	CcSEcCtD
Irbesartan—Myalgia—Pregabalin—epilepsy syndrome	3.17e-05	0.0002	CcSEcCtD
Irbesartan—Arthralgia—Pregabalin—epilepsy syndrome	3.17e-05	0.0002	CcSEcCtD
Irbesartan—Chest pain—Pregabalin—epilepsy syndrome	3.17e-05	0.0002	CcSEcCtD
Irbesartan—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.16e-05	0.0002	CcSEcCtD
Irbesartan—Dizziness—Zonisamide—epilepsy syndrome	3.16e-05	0.0002	CcSEcCtD
Irbesartan—Headache—Diazepam—epilepsy syndrome	3.16e-05	0.0002	CcSEcCtD
Irbesartan—Anxiety—Pregabalin—epilepsy syndrome	3.16e-05	0.000199	CcSEcCtD
Irbesartan—Diarrhoea—Clonazepam—epilepsy syndrome	3.15e-05	0.000199	CcSEcCtD
Irbesartan—Anaemia—Gabapentin—epilepsy syndrome	3.15e-05	0.000199	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.14e-05	0.000199	CcSEcCtD
Irbesartan—Hypotension—Valproic Acid—epilepsy syndrome	3.14e-05	0.000198	CcSEcCtD
Irbesartan—Asthenia—Carbamazepine—epilepsy syndrome	3.14e-05	0.000198	CcSEcCtD
Irbesartan—Agitation—Gabapentin—epilepsy syndrome	3.13e-05	0.000198	CcSEcCtD
Irbesartan—Diarrhoea—Phenytoin—epilepsy syndrome	3.13e-05	0.000198	CcSEcCtD
Irbesartan—Discomfort—Pregabalin—epilepsy syndrome	3.13e-05	0.000198	CcSEcCtD
Irbesartan—Nausea—Fosphenytoin—epilepsy syndrome	3.13e-05	0.000198	CcSEcCtD
Irbesartan—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.12e-05	0.000197	CcSEcCtD
Irbesartan—Angioedema—Gabapentin—epilepsy syndrome	3.12e-05	0.000197	CcSEcCtD
Irbesartan—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.11e-05	0.000197	CcSEcCtD
Irbesartan—Vomiting—Felbamate—epilepsy syndrome	3.11e-05	0.000196	CcSEcCtD
Irbesartan—Dry mouth—Pregabalin—epilepsy syndrome	3.1e-05	0.000196	CcSEcCtD
Irbesartan—Pruritus—Carbamazepine—epilepsy syndrome	3.09e-05	0.000195	CcSEcCtD
Irbesartan—Rash—Felbamate—epilepsy syndrome	3.08e-05	0.000195	CcSEcCtD
Irbesartan—Dermatitis—Felbamate—epilepsy syndrome	3.08e-05	0.000195	CcSEcCtD
Irbesartan—Malaise—Gabapentin—epilepsy syndrome	3.08e-05	0.000194	CcSEcCtD
Irbesartan—Tinnitus—Topiramate—epilepsy syndrome	3.07e-05	0.000194	CcSEcCtD
Irbesartan—Vertigo—Gabapentin—epilepsy syndrome	3.06e-05	0.000194	CcSEcCtD
Irbesartan—Headache—Felbamate—epilepsy syndrome	3.06e-05	0.000193	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.06e-05	0.000193	CcSEcCtD
Irbesartan—Flushing—Topiramate—epilepsy syndrome	3.06e-05	0.000193	CcSEcCtD
Irbesartan—Cardiac disorder—Topiramate—epilepsy syndrome	3.06e-05	0.000193	CcSEcCtD
Irbesartan—Syncope—Gabapentin—epilepsy syndrome	3.06e-05	0.000193	CcSEcCtD
Irbesartan—Leukopenia—Gabapentin—epilepsy syndrome	3.05e-05	0.000193	CcSEcCtD
Irbesartan—Dizziness—Clonazepam—epilepsy syndrome	3.05e-05	0.000193	CcSEcCtD
Irbesartan—Nausea—Vigabatrin—epilepsy syndrome	3.05e-05	0.000193	CcSEcCtD
Irbesartan—Vomiting—Zonisamide—epilepsy syndrome	3.04e-05	0.000192	CcSEcCtD
Irbesartan—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.04e-05	0.000192	CcSEcCtD
Irbesartan—Oedema—Pregabalin—epilepsy syndrome	3.04e-05	0.000192	CcSEcCtD
Irbesartan—Asthenia—Lamotrigine—epilepsy syndrome	3.03e-05	0.000192	CcSEcCtD
Irbesartan—Dizziness—Phenytoin—epilepsy syndrome	3.03e-05	0.000191	CcSEcCtD
Irbesartan—Rash—Zonisamide—epilepsy syndrome	3.02e-05	0.000191	CcSEcCtD
Irbesartan—Infection—Pregabalin—epilepsy syndrome	3.02e-05	0.000191	CcSEcCtD
Irbesartan—Paraesthesia—Valproic Acid—epilepsy syndrome	3.01e-05	0.000191	CcSEcCtD
Irbesartan—Dermatitis—Zonisamide—epilepsy syndrome	3.01e-05	0.00019	CcSEcCtD
Irbesartan—Dizziness—Oxcarbazepine—epilepsy syndrome	3.01e-05	0.00019	CcSEcCtD
Irbesartan—Nausea—Diazepam—epilepsy syndrome	3e-05	0.00019	CcSEcCtD
Irbesartan—Loss of consciousness—Gabapentin—epilepsy syndrome	3e-05	0.000189	CcSEcCtD
Irbesartan—Headache—Zonisamide—epilepsy syndrome	3e-05	0.000189	CcSEcCtD
Irbesartan—Dyspnoea—Valproic Acid—epilepsy syndrome	2.99e-05	0.000189	CcSEcCtD
Irbesartan—Diarrhoea—Carbamazepine—epilepsy syndrome	2.99e-05	0.000189	CcSEcCtD
Irbesartan—Angiopathy—Topiramate—epilepsy syndrome	2.99e-05	0.000189	CcSEcCtD
Irbesartan—Pruritus—Lamotrigine—epilepsy syndrome	2.99e-05	0.000189	CcSEcCtD
Irbesartan—Shock—Pregabalin—epilepsy syndrome	2.99e-05	0.000189	CcSEcCtD
Irbesartan—Somnolence—Valproic Acid—epilepsy syndrome	2.98e-05	0.000189	CcSEcCtD
Irbesartan—Immune system disorder—Topiramate—epilepsy syndrome	2.98e-05	0.000188	CcSEcCtD
Irbesartan—Nervous system disorder—Pregabalin—epilepsy syndrome	2.98e-05	0.000188	CcSEcCtD
Irbesartan—Cough—Gabapentin—epilepsy syndrome	2.98e-05	0.000188	CcSEcCtD
Irbesartan—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.97e-05	0.000188	CcSEcCtD
Irbesartan—Mediastinal disorder—Topiramate—epilepsy syndrome	2.97e-05	0.000188	CcSEcCtD
Irbesartan—Tachycardia—Pregabalin—epilepsy syndrome	2.96e-05	0.000187	CcSEcCtD
Irbesartan—Chills—Topiramate—epilepsy syndrome	2.96e-05	0.000187	CcSEcCtD
Irbesartan—Dyspepsia—Valproic Acid—epilepsy syndrome	2.96e-05	0.000187	CcSEcCtD
Irbesartan—Skin disorder—Pregabalin—epilepsy syndrome	2.95e-05	0.000186	CcSEcCtD
Irbesartan—Hypertension—Gabapentin—epilepsy syndrome	2.94e-05	0.000186	CcSEcCtD
Irbesartan—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.93e-05	0.000185	CcSEcCtD
Irbesartan—Vomiting—Clonazepam—epilepsy syndrome	2.93e-05	0.000185	CcSEcCtD
Irbesartan—Decreased appetite—Valproic Acid—epilepsy syndrome	2.92e-05	0.000184	CcSEcCtD
Irbesartan—Vomiting—Phenytoin—epilepsy syndrome	2.91e-05	0.000184	CcSEcCtD
Irbesartan—Rash—Clonazepam—epilepsy syndrome	2.91e-05	0.000184	CcSEcCtD
Irbesartan—Dermatitis—Clonazepam—epilepsy syndrome	2.9e-05	0.000184	CcSEcCtD
Irbesartan—Arthralgia—Gabapentin—epilepsy syndrome	2.9e-05	0.000183	CcSEcCtD
Irbesartan—Myalgia—Gabapentin—epilepsy syndrome	2.9e-05	0.000183	CcSEcCtD
Irbesartan—Chest pain—Gabapentin—epilepsy syndrome	2.9e-05	0.000183	CcSEcCtD
Irbesartan—Nausea—Felbamate—epilepsy syndrome	2.9e-05	0.000183	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.9e-05	0.000183	CcSEcCtD
Irbesartan—Vomiting—Oxcarbazepine—epilepsy syndrome	2.9e-05	0.000183	CcSEcCtD
Irbesartan—Fatigue—Valproic Acid—epilepsy syndrome	2.89e-05	0.000183	CcSEcCtD
Irbesartan—Anxiety—Gabapentin—epilepsy syndrome	2.89e-05	0.000183	CcSEcCtD
Irbesartan—Anorexia—Pregabalin—epilepsy syndrome	2.89e-05	0.000183	CcSEcCtD
Irbesartan—Dizziness—Carbamazepine—epilepsy syndrome	2.89e-05	0.000183	CcSEcCtD
Irbesartan—Diarrhoea—Lamotrigine—epilepsy syndrome	2.89e-05	0.000183	CcSEcCtD
Irbesartan—Headache—Clonazepam—epilepsy syndrome	2.89e-05	0.000183	CcSEcCtD
Irbesartan—Rash—Phenytoin—epilepsy syndrome	2.89e-05	0.000182	CcSEcCtD
Irbesartan—Dermatitis—Phenytoin—epilepsy syndrome	2.88e-05	0.000182	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.88e-05	0.000182	CcSEcCtD
Irbesartan—Rash—Oxcarbazepine—epilepsy syndrome	2.87e-05	0.000182	CcSEcCtD
Irbesartan—Pain—Valproic Acid—epilepsy syndrome	2.87e-05	0.000181	CcSEcCtD
Irbesartan—Constipation—Valproic Acid—epilepsy syndrome	2.87e-05	0.000181	CcSEcCtD
Irbesartan—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.87e-05	0.000181	CcSEcCtD
Irbesartan—Headache—Phenytoin—epilepsy syndrome	2.87e-05	0.000181	CcSEcCtD
Irbesartan—Erythema—Topiramate—epilepsy syndrome	2.87e-05	0.000181	CcSEcCtD
Irbesartan—Malnutrition—Topiramate—epilepsy syndrome	2.87e-05	0.000181	CcSEcCtD
Irbesartan—Discomfort—Gabapentin—epilepsy syndrome	2.87e-05	0.000181	CcSEcCtD
Irbesartan—Headache—Oxcarbazepine—epilepsy syndrome	2.85e-05	0.00018	CcSEcCtD
Irbesartan—Nausea—Zonisamide—epilepsy syndrome	2.84e-05	0.00018	CcSEcCtD
Irbesartan—Dry mouth—Gabapentin—epilepsy syndrome	2.84e-05	0.000179	CcSEcCtD
Irbesartan—Hypotension—Pregabalin—epilepsy syndrome	2.84e-05	0.000179	CcSEcCtD
Irbesartan—Flatulence—Topiramate—epilepsy syndrome	2.83e-05	0.000179	CcSEcCtD
Irbesartan—Tension—Topiramate—epilepsy syndrome	2.82e-05	0.000178	CcSEcCtD
Irbesartan—Dysgeusia—Topiramate—epilepsy syndrome	2.81e-05	0.000178	CcSEcCtD
Irbesartan—Dizziness—Lamotrigine—epilepsy syndrome	2.79e-05	0.000177	CcSEcCtD
Irbesartan—Nervousness—Topiramate—epilepsy syndrome	2.79e-05	0.000176	CcSEcCtD
Irbesartan—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.78e-05	0.000176	CcSEcCtD
Irbesartan—Oedema—Gabapentin—epilepsy syndrome	2.78e-05	0.000176	CcSEcCtD
Irbesartan—Vomiting—Carbamazepine—epilepsy syndrome	2.78e-05	0.000176	CcSEcCtD
Irbesartan—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.77e-05	0.000175	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.77e-05	0.000175	CcSEcCtD
Irbesartan—Infection—Gabapentin—epilepsy syndrome	2.76e-05	0.000175	CcSEcCtD
Irbesartan—Muscle spasms—Topiramate—epilepsy syndrome	2.76e-05	0.000174	CcSEcCtD
Irbesartan—Rash—Carbamazepine—epilepsy syndrome	2.76e-05	0.000174	CcSEcCtD
Irbesartan—Dermatitis—Carbamazepine—epilepsy syndrome	2.75e-05	0.000174	CcSEcCtD
Irbesartan—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.75e-05	0.000173	CcSEcCtD
Irbesartan—Nausea—Clonazepam—epilepsy syndrome	2.74e-05	0.000173	CcSEcCtD
Irbesartan—Headache—Carbamazepine—epilepsy syndrome	2.74e-05	0.000173	CcSEcCtD
Irbesartan—Shock—Gabapentin—epilepsy syndrome	2.74e-05	0.000173	CcSEcCtD
Irbesartan—Nervous system disorder—Gabapentin—epilepsy syndrome	2.73e-05	0.000172	CcSEcCtD
Irbesartan—Paraesthesia—Pregabalin—epilepsy syndrome	2.73e-05	0.000172	CcSEcCtD
Irbesartan—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.73e-05	0.000172	CcSEcCtD
Irbesartan—Nausea—Phenytoin—epilepsy syndrome	2.72e-05	0.000172	CcSEcCtD
Irbesartan—Tachycardia—Gabapentin—epilepsy syndrome	2.72e-05	0.000172	CcSEcCtD
Irbesartan—Dyspnoea—Pregabalin—epilepsy syndrome	2.71e-05	0.000171	CcSEcCtD
Irbesartan—Nausea—Oxcarbazepine—epilepsy syndrome	2.71e-05	0.000171	CcSEcCtD
Irbesartan—Vision blurred—Topiramate—epilepsy syndrome	2.7e-05	0.000171	CcSEcCtD
Irbesartan—Skin disorder—Gabapentin—epilepsy syndrome	2.7e-05	0.000171	CcSEcCtD
Irbesartan—Somnolence—Pregabalin—epilepsy syndrome	2.7e-05	0.000171	CcSEcCtD
Irbesartan—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.69e-05	0.00017	CcSEcCtD
Irbesartan—Tremor—Topiramate—epilepsy syndrome	2.69e-05	0.00017	CcSEcCtD
Irbesartan—Vomiting—Lamotrigine—epilepsy syndrome	2.69e-05	0.00017	CcSEcCtD
Irbesartan—Urticaria—Valproic Acid—epilepsy syndrome	2.67e-05	0.000169	CcSEcCtD
Irbesartan—Rash—Lamotrigine—epilepsy syndrome	2.66e-05	0.000168	CcSEcCtD
Irbesartan—Ill-defined disorder—Topiramate—epilepsy syndrome	2.66e-05	0.000168	CcSEcCtD
Irbesartan—Dermatitis—Lamotrigine—epilepsy syndrome	2.66e-05	0.000168	CcSEcCtD
Irbesartan—Body temperature increased—Valproic Acid—epilepsy syndrome	2.65e-05	0.000168	CcSEcCtD
Irbesartan—Abdominal pain—Valproic Acid—epilepsy syndrome	2.65e-05	0.000168	CcSEcCtD
Irbesartan—Anorexia—Gabapentin—epilepsy syndrome	2.65e-05	0.000168	CcSEcCtD
Irbesartan—Anaemia—Topiramate—epilepsy syndrome	2.65e-05	0.000168	CcSEcCtD
Irbesartan—Headache—Lamotrigine—epilepsy syndrome	2.65e-05	0.000167	CcSEcCtD
Irbesartan—Decreased appetite—Pregabalin—epilepsy syndrome	2.64e-05	0.000167	CcSEcCtD
Irbesartan—Agitation—Topiramate—epilepsy syndrome	2.64e-05	0.000167	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.62e-05	0.000166	CcSEcCtD
Irbesartan—Fatigue—Pregabalin—epilepsy syndrome	2.62e-05	0.000165	CcSEcCtD
Irbesartan—Hypotension—Gabapentin—epilepsy syndrome	2.6e-05	0.000164	CcSEcCtD
Irbesartan—Nausea—Carbamazepine—epilepsy syndrome	2.6e-05	0.000164	CcSEcCtD
Irbesartan—Pain—Pregabalin—epilepsy syndrome	2.6e-05	0.000164	CcSEcCtD
Irbesartan—Constipation—Pregabalin—epilepsy syndrome	2.6e-05	0.000164	CcSEcCtD
Irbesartan—Malaise—Topiramate—epilepsy syndrome	2.59e-05	0.000164	CcSEcCtD
Irbesartan—Vertigo—Topiramate—epilepsy syndrome	2.58e-05	0.000163	CcSEcCtD
Irbesartan—Syncope—Topiramate—epilepsy syndrome	2.57e-05	0.000163	CcSEcCtD
Irbesartan—Leukopenia—Topiramate—epilepsy syndrome	2.57e-05	0.000162	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.54e-05	0.00016	CcSEcCtD
Irbesartan—Loss of consciousness—Topiramate—epilepsy syndrome	2.52e-05	0.000159	CcSEcCtD
Irbesartan—Nausea—Lamotrigine—epilepsy syndrome	2.51e-05	0.000159	CcSEcCtD
Irbesartan—Cough—Topiramate—epilepsy syndrome	2.5e-05	0.000158	CcSEcCtD
Irbesartan—Feeling abnormal—Pregabalin—epilepsy syndrome	2.5e-05	0.000158	CcSEcCtD
Irbesartan—Paraesthesia—Gabapentin—epilepsy syndrome	2.5e-05	0.000158	CcSEcCtD
Irbesartan—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.48e-05	0.000157	CcSEcCtD
Irbesartan—Dyspnoea—Gabapentin—epilepsy syndrome	2.48e-05	0.000157	CcSEcCtD
Irbesartan—Hypertension—Topiramate—epilepsy syndrome	2.48e-05	0.000157	CcSEcCtD
Irbesartan—Somnolence—Gabapentin—epilepsy syndrome	2.47e-05	0.000156	CcSEcCtD
Irbesartan—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.47e-05	0.000156	CcSEcCtD
Irbesartan—Dyspepsia—Gabapentin—epilepsy syndrome	2.45e-05	0.000155	CcSEcCtD
Irbesartan—Arthralgia—Topiramate—epilepsy syndrome	2.44e-05	0.000154	CcSEcCtD
Irbesartan—Chest pain—Topiramate—epilepsy syndrome	2.44e-05	0.000154	CcSEcCtD
Irbesartan—Myalgia—Topiramate—epilepsy syndrome	2.44e-05	0.000154	CcSEcCtD
Irbesartan—Anxiety—Topiramate—epilepsy syndrome	2.43e-05	0.000154	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.43e-05	0.000153	CcSEcCtD
Irbesartan—Decreased appetite—Gabapentin—epilepsy syndrome	2.42e-05	0.000153	CcSEcCtD
Irbesartan—Discomfort—Topiramate—epilepsy syndrome	2.41e-05	0.000153	CcSEcCtD
Irbesartan—Urticaria—Pregabalin—epilepsy syndrome	2.41e-05	0.000152	CcSEcCtD
Irbesartan—Asthenia—Valproic Acid—epilepsy syndrome	2.41e-05	0.000152	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.4e-05	0.000152	CcSEcCtD
Irbesartan—Fatigue—Gabapentin—epilepsy syndrome	2.4e-05	0.000152	CcSEcCtD
Irbesartan—Abdominal pain—Pregabalin—epilepsy syndrome	2.4e-05	0.000152	CcSEcCtD
Irbesartan—Body temperature increased—Pregabalin—epilepsy syndrome	2.4e-05	0.000152	CcSEcCtD
Irbesartan—Dry mouth—Topiramate—epilepsy syndrome	2.39e-05	0.000151	CcSEcCtD
Irbesartan—Pain—Gabapentin—epilepsy syndrome	2.38e-05	0.00015	CcSEcCtD
Irbesartan—Constipation—Gabapentin—epilepsy syndrome	2.38e-05	0.00015	CcSEcCtD
Irbesartan—Pruritus—Valproic Acid—epilepsy syndrome	2.38e-05	0.00015	CcSEcCtD
Irbesartan—Oedema—Topiramate—epilepsy syndrome	2.34e-05	0.000148	CcSEcCtD
Irbesartan—Infection—Topiramate—epilepsy syndrome	2.33e-05	0.000147	CcSEcCtD
Irbesartan—Shock—Topiramate—epilepsy syndrome	2.3e-05	0.000146	CcSEcCtD
Irbesartan—Diarrhoea—Valproic Acid—epilepsy syndrome	2.3e-05	0.000145	CcSEcCtD
Irbesartan—Nervous system disorder—Topiramate—epilepsy syndrome	2.3e-05	0.000145	CcSEcCtD
Irbesartan—Feeling abnormal—Gabapentin—epilepsy syndrome	2.29e-05	0.000145	CcSEcCtD
Irbesartan—Thrombocytopenia—Topiramate—epilepsy syndrome	2.29e-05	0.000145	CcSEcCtD
Irbesartan—Tachycardia—Topiramate—epilepsy syndrome	2.29e-05	0.000144	CcSEcCtD
Irbesartan—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.28e-05	0.000144	CcSEcCtD
Irbesartan—Skin disorder—Topiramate—epilepsy syndrome	2.27e-05	0.000144	CcSEcCtD
Irbesartan—Hyperhidrosis—Topiramate—epilepsy syndrome	2.26e-05	0.000143	CcSEcCtD
Irbesartan—Hypersensitivity—Pregabalin—epilepsy syndrome	2.24e-05	0.000141	CcSEcCtD
Irbesartan—Anorexia—Topiramate—epilepsy syndrome	2.23e-05	0.000141	CcSEcCtD
Irbesartan—Dizziness—Valproic Acid—epilepsy syndrome	2.22e-05	0.00014	CcSEcCtD
Irbesartan—Urticaria—Gabapentin—epilepsy syndrome	2.21e-05	0.00014	CcSEcCtD
Irbesartan—Body temperature increased—Gabapentin—epilepsy syndrome	2.2e-05	0.000139	CcSEcCtD
Irbesartan—Abdominal pain—Gabapentin—epilepsy syndrome	2.2e-05	0.000139	CcSEcCtD
Irbesartan—Hypotension—Topiramate—epilepsy syndrome	2.19e-05	0.000138	CcSEcCtD
Irbesartan—Asthenia—Pregabalin—epilepsy syndrome	2.18e-05	0.000138	CcSEcCtD
Irbesartan—Pruritus—Pregabalin—epilepsy syndrome	2.15e-05	0.000136	CcSEcCtD
Irbesartan—Vomiting—Valproic Acid—epilepsy syndrome	2.13e-05	0.000135	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.13e-05	0.000135	CcSEcCtD
Irbesartan—Rash—Valproic Acid—epilepsy syndrome	2.12e-05	0.000134	CcSEcCtD
Irbesartan—Dermatitis—Valproic Acid—epilepsy syndrome	2.11e-05	0.000134	CcSEcCtD
Irbesartan—Headache—Valproic Acid—epilepsy syndrome	2.1e-05	0.000133	CcSEcCtD
Irbesartan—Paraesthesia—Topiramate—epilepsy syndrome	2.1e-05	0.000133	CcSEcCtD
Irbesartan—Dyspnoea—Topiramate—epilepsy syndrome	2.09e-05	0.000132	CcSEcCtD
Irbesartan—Somnolence—Topiramate—epilepsy syndrome	2.08e-05	0.000132	CcSEcCtD
Irbesartan—Diarrhoea—Pregabalin—epilepsy syndrome	2.08e-05	0.000131	CcSEcCtD
Irbesartan—Dyspepsia—Topiramate—epilepsy syndrome	2.06e-05	0.00013	CcSEcCtD
Irbesartan—Hypersensitivity—Gabapentin—epilepsy syndrome	2.05e-05	0.00013	CcSEcCtD
Irbesartan—Decreased appetite—Topiramate—epilepsy syndrome	2.04e-05	0.000129	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.02e-05	0.000128	CcSEcCtD
Irbesartan—Fatigue—Topiramate—epilepsy syndrome	2.02e-05	0.000128	CcSEcCtD
Irbesartan—Dizziness—Pregabalin—epilepsy syndrome	2.01e-05	0.000127	CcSEcCtD
Irbesartan—Pain—Topiramate—epilepsy syndrome	2e-05	0.000127	CcSEcCtD
Irbesartan—Constipation—Topiramate—epilepsy syndrome	2e-05	0.000127	CcSEcCtD
Irbesartan—Asthenia—Gabapentin—epilepsy syndrome	2e-05	0.000126	CcSEcCtD
Irbesartan—Nausea—Valproic Acid—epilepsy syndrome	1.99e-05	0.000126	CcSEcCtD
Irbesartan—Pruritus—Gabapentin—epilepsy syndrome	1.97e-05	0.000124	CcSEcCtD
Irbesartan—Vomiting—Pregabalin—epilepsy syndrome	1.93e-05	0.000122	CcSEcCtD
Irbesartan—Feeling abnormal—Topiramate—epilepsy syndrome	1.93e-05	0.000122	CcSEcCtD
Irbesartan—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.91e-05	0.000121	CcSEcCtD
Irbesartan—Rash—Pregabalin—epilepsy syndrome	1.91e-05	0.000121	CcSEcCtD
Irbesartan—Dermatitis—Pregabalin—epilepsy syndrome	1.91e-05	0.000121	CcSEcCtD
Irbesartan—Diarrhoea—Gabapentin—epilepsy syndrome	1.9e-05	0.00012	CcSEcCtD
Irbesartan—Headache—Pregabalin—epilepsy syndrome	1.9e-05	0.00012	CcSEcCtD
Irbesartan—Urticaria—Topiramate—epilepsy syndrome	1.86e-05	0.000118	CcSEcCtD
Irbesartan—Body temperature increased—Topiramate—epilepsy syndrome	1.85e-05	0.000117	CcSEcCtD
Irbesartan—Abdominal pain—Topiramate—epilepsy syndrome	1.85e-05	0.000117	CcSEcCtD
Irbesartan—Dizziness—Gabapentin—epilepsy syndrome	1.84e-05	0.000116	CcSEcCtD
Irbesartan—Nausea—Pregabalin—epilepsy syndrome	1.8e-05	0.000114	CcSEcCtD
Irbesartan—Vomiting—Gabapentin—epilepsy syndrome	1.77e-05	0.000112	CcSEcCtD
Irbesartan—Rash—Gabapentin—epilepsy syndrome	1.75e-05	0.000111	CcSEcCtD
Irbesartan—Dermatitis—Gabapentin—epilepsy syndrome	1.75e-05	0.000111	CcSEcCtD
Irbesartan—Headache—Gabapentin—epilepsy syndrome	1.74e-05	0.00011	CcSEcCtD
Irbesartan—Hypersensitivity—Topiramate—epilepsy syndrome	1.73e-05	0.000109	CcSEcCtD
Irbesartan—Asthenia—Topiramate—epilepsy syndrome	1.68e-05	0.000106	CcSEcCtD
Irbesartan—Pruritus—Topiramate—epilepsy syndrome	1.66e-05	0.000105	CcSEcCtD
Irbesartan—Nausea—Gabapentin—epilepsy syndrome	1.65e-05	0.000104	CcSEcCtD
Irbesartan—Diarrhoea—Topiramate—epilepsy syndrome	1.6e-05	0.000101	CcSEcCtD
Irbesartan—Dizziness—Topiramate—epilepsy syndrome	1.55e-05	9.79e-05	CcSEcCtD
Irbesartan—Vomiting—Topiramate—epilepsy syndrome	1.49e-05	9.41e-05	CcSEcCtD
Irbesartan—Rash—Topiramate—epilepsy syndrome	1.48e-05	9.33e-05	CcSEcCtD
Irbesartan—Dermatitis—Topiramate—epilepsy syndrome	1.47e-05	9.32e-05	CcSEcCtD
Irbesartan—Headache—Topiramate—epilepsy syndrome	1.47e-05	9.27e-05	CcSEcCtD
Irbesartan—Nausea—Topiramate—epilepsy syndrome	1.39e-05	8.79e-05	CcSEcCtD
Irbesartan—CYP2C9—Metabolism—ADSL—epilepsy syndrome	4.03e-06	4.33e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—AGT—epilepsy syndrome	4.02e-06	4.33e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—S100B—epilepsy syndrome	3.98e-06	4.29e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GLUL—epilepsy syndrome	3.98e-06	4.29e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	3.97e-06	4.27e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GLUL—epilepsy syndrome	3.95e-06	4.25e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SOCS3—epilepsy syndrome	3.94e-06	4.25e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—APOE—epilepsy syndrome	3.94e-06	4.25e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CDC42—epilepsy syndrome	3.93e-06	4.24e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—FOS—epilepsy syndrome	3.92e-06	4.22e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	3.91e-06	4.21e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	3.91e-06	4.21e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	3.91e-06	4.21e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—SLC2A1—epilepsy syndrome	3.9e-06	4.2e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	3.87e-06	4.17e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—KDR—epilepsy syndrome	3.86e-06	4.16e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	3.86e-06	4.16e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PLCB1—epilepsy syndrome	3.86e-06	4.15e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—TH—epilepsy syndrome	3.84e-06	4.14e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—CASP8—epilepsy syndrome	3.83e-06	4.12e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	3.83e-06	4.12e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	3.83e-06	4.12e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	3.83e-06	4.12e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PFKL—epilepsy syndrome	3.83e-06	4.12e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	3.83e-06	4.12e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—FGF2—epilepsy syndrome	3.82e-06	4.11e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—AVP—epilepsy syndrome	3.81e-06	4.1e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.78e-06	4.07e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NT5E—epilepsy syndrome	3.76e-06	4.05e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALAD—epilepsy syndrome	3.76e-06	4.05e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—POMC—epilepsy syndrome	3.75e-06	4.04e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PRKCB—epilepsy syndrome	3.72e-06	4e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL6ST—epilepsy syndrome	3.7e-06	3.99e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	3.66e-06	3.94e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.64e-06	3.92e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	3.62e-06	3.9e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HES1—epilepsy syndrome	3.6e-06	3.88e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	3.59e-06	3.86e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	3.59e-06	3.86e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.57e-06	3.84e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—AQP1—epilepsy syndrome	3.55e-06	3.82e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—RELA—epilepsy syndrome	3.54e-06	3.82e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—AQP1—epilepsy syndrome	3.52e-06	3.79e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	3.51e-06	3.78e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NEU1—epilepsy syndrome	3.5e-06	3.77e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ATIC—epilepsy syndrome	3.5e-06	3.77e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—UPB1—epilepsy syndrome	3.5e-06	3.77e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—FYN—epilepsy syndrome	3.5e-06	3.77e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—H2AFX—epilepsy syndrome	3.49e-06	3.76e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MEF2C—epilepsy syndrome	3.48e-06	3.75e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MTOR—epilepsy syndrome	3.48e-06	3.74e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—FGF2—epilepsy syndrome	3.46e-06	3.73e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ADSL—epilepsy syndrome	3.44e-06	3.7e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ALB—epilepsy syndrome	3.42e-06	3.68e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—POMC—epilepsy syndrome	3.39e-06	3.65e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.38e-06	3.64e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GLUL—epilepsy syndrome	3.37e-06	3.63e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	3.37e-06	3.63e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—YWHAZ—epilepsy syndrome	3.37e-06	3.62e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NGF—epilepsy syndrome	3.33e-06	3.58e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCL2—epilepsy syndrome	3.31e-06	3.57e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	3.31e-06	3.57e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—BCL2—epilepsy syndrome	3.29e-06	3.54e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	3.26e-06	3.51e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GBE1—epilepsy syndrome	3.26e-06	3.51e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCR5—epilepsy syndrome	3.24e-06	3.49e-05	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—AKT1—epilepsy syndrome	3.23e-06	3.47e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—RELA—epilepsy syndrome	3.21e-06	3.46e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	3.21e-06	3.46e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	3.21e-06	3.46e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—HMOX1—epilepsy syndrome	3.21e-06	3.45e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CASP3—epilepsy syndrome	3.2e-06	3.44e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	3.19e-06	3.43e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	3.18e-06	3.43e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	3.18e-06	3.43e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HTR2A—epilepsy syndrome	3.17e-06	3.41e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CAT—epilepsy syndrome	3.17e-06	3.41e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—MTOR—epilepsy syndrome	3.15e-06	3.39e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	3.11e-06	3.34e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—JUN—epilepsy syndrome	3.1e-06	3.34e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	3.1e-06	3.33e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	3.09e-06	3.32e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ABCB1—epilepsy syndrome	3.08e-06	3.32e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.06e-06	3.3e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	3.06e-06	3.3e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MMP9—epilepsy syndrome	3.02e-06	3.25e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TSC2—epilepsy syndrome	3.01e-06	3.24e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—AGT—epilepsy syndrome	3.01e-06	3.24e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—AQP1—epilepsy syndrome	3.01e-06	3.24e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—FGF2—epilepsy syndrome	3e-06	3.23e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PTGS2—epilepsy syndrome	2.99e-06	3.22e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.98e-06	3.21e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.96e-06	3.19e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—APOE—epilepsy syndrome	2.95e-06	3.17e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—AKT1—epilepsy syndrome	2.93e-06	3.15e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL1B—epilepsy syndrome	2.91e-06	3.13e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.9e-06	3.13e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.9e-06	3.13e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.9e-06	3.13e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.89e-06	3.11e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—KDR—epilepsy syndrome	2.89e-06	3.11e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GPX1—epilepsy syndrome	2.86e-06	3.08e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.79e-06	3.01e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	2.79e-06	3e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—SRC—epilepsy syndrome	2.79e-06	3e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—RELA—epilepsy syndrome	2.78e-06	2.99e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PRKCB—epilepsy syndrome	2.78e-06	2.99e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.77e-06	2.98e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.77e-06	2.98e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6ST—epilepsy syndrome	2.77e-06	2.98e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MTOR—epilepsy syndrome	2.73e-06	2.94e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	2.72e-06	2.93e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	2.72e-06	2.93e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—VEGFA—epilepsy syndrome	2.71e-06	2.92e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.71e-06	2.92e-05	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—AKT1—epilepsy syndrome	2.69e-06	2.9e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.65e-06	2.86e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	2.65e-06	2.86e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—BCHE—epilepsy syndrome	2.64e-06	2.84e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	2.62e-06	2.82e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.6e-06	2.8e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	2.59e-06	2.79e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.56e-06	2.75e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.55e-06	2.75e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2.53e-06	2.73e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.53e-06	2.73e-05	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.53e-06	2.73e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—POMC—epilepsy syndrome	2.53e-06	2.73e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	2.53e-06	2.72e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—SRC—epilepsy syndrome	2.53e-06	2.72e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	2.52e-06	2.71e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	2.51e-06	2.7e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—AGT—epilepsy syndrome	2.51e-06	2.7e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CASP3—epilepsy syndrome	2.51e-06	2.7e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.49e-06	2.69e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	2.49e-06	2.68e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—TH—epilepsy syndrome	2.48e-06	2.67e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.48e-06	2.67e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCL2—epilepsy syndrome	2.48e-06	2.67e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—APOE—epilepsy syndrome	2.46e-06	2.65e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.44e-06	2.63e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—JUN—epilepsy syndrome	2.44e-06	2.62e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.39e-06	2.57e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MMP9—epilepsy syndrome	2.37e-06	2.55e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.32e-06	2.5e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—AKT1—epilepsy syndrome	2.3e-06	2.48e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.27e-06	2.45e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	2.27e-06	2.44e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—FGF2—epilepsy syndrome	2.24e-06	2.41e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	2.22e-06	2.39e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SRC—epilepsy syndrome	2.19e-06	2.35e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	2.18e-06	2.34e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—BCHE—epilepsy syndrome	2.17e-06	2.33e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	2.16e-06	2.33e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	2.16e-06	2.32e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2.15e-06	2.31e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	2.15e-06	2.31e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.13e-06	2.29e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—VEGFA—epilepsy syndrome	2.13e-06	2.29e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—POMC—epilepsy syndrome	2.11e-06	2.28e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.1e-06	2.26e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.1e-06	2.26e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—RELA—epilepsy syndrome	2.08e-06	2.24e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	2.07e-06	2.23e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.07e-06	2.23e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	2.05e-06	2.21e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.05e-06	2.2e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CAT—epilepsy syndrome	2.04e-06	2.2e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—TH—epilepsy syndrome	2.04e-06	2.19e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MTOR—epilepsy syndrome	2.04e-06	2.19e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	2.03e-06	2.18e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—TH—epilepsy syndrome	2.02e-06	2.18e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.99e-06	2.14e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	1.99e-06	2.14e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.94e-06	2.09e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.94e-06	2.09e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ALB—epilepsy syndrome	1.93e-06	2.07e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CASP3—epilepsy syndrome	1.87e-06	2.02e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GPX1—epilepsy syndrome	1.85e-06	1.99e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.84e-06	1.99e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.84e-06	1.98e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MMP9—epilepsy syndrome	1.77e-06	1.91e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.75e-06	1.89e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.73e-06	1.87e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—AKT1—epilepsy syndrome	1.73e-06	1.86e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—TH—epilepsy syndrome	1.73e-06	1.86e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.71e-06	1.84e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.7e-06	1.83e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.7e-06	1.83e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.69e-06	1.82e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PTGS2—epilepsy syndrome	1.69e-06	1.81e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.68e-06	1.81e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.67e-06	1.79e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.66e-06	1.79e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.66e-06	1.78e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.63e-06	1.76e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SRC—epilepsy syndrome	1.63e-06	1.76e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—AGT—epilepsy syndrome	1.62e-06	1.75e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.62e-06	1.74e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—VEGFA—epilepsy syndrome	1.59e-06	1.71e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOE—epilepsy syndrome	1.59e-06	1.71e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—AKT1—epilepsy syndrome	1.57e-06	1.69e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.52e-06	1.63e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.51e-06	1.62e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—AKT1—epilepsy syndrome	1.5e-06	1.62e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.5e-06	1.61e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.44e-06	1.55e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.42e-06	1.53e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.42e-06	1.53e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.42e-06	1.53e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.38e-06	1.49e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—POMC—epilepsy syndrome	1.36e-06	1.47e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—AKT1—epilepsy syndrome	1.36e-06	1.46e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.35e-06	1.46e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.34e-06	1.44e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—TH—epilepsy syndrome	1.33e-06	1.43e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.33e-06	1.43e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.32e-06	1.42e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.3e-06	1.4e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.29e-06	1.39e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.29e-06	1.38e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.24e-06	1.34e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.13e-06	1.21e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.12e-06	1.21e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.11e-06	1.2e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.11e-06	1.2e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.1e-06	1.19e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.1e-06	1.18e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.09e-06	1.17e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.07e-06	1.15e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.02e-06	1.1e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—AKT1—epilepsy syndrome	1.01e-06	1.09e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.01e-06	1.09e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GPX1—epilepsy syndrome	9.93e-07	1.07e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—POMC—epilepsy syndrome	9.49e-07	1.02e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	8.94e-07	9.62e-06	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	8.86e-07	9.54e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—AGT—epilepsy syndrome	8.7e-07	9.37e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALB—epilepsy syndrome	8.65e-07	9.32e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOE—epilepsy syndrome	8.53e-07	9.18e-06	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—AKT1—epilepsy syndrome	8.47e-07	9.12e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	7.57e-07	8.15e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—POMC—epilepsy syndrome	7.33e-07	7.89e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALB—epilepsy syndrome	6.68e-07	7.19e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	5.84e-07	6.29e-06	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—AKT1—epilepsy syndrome	5.47e-07	5.89e-06	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—AKT1—epilepsy syndrome	4.49e-07	4.84e-06	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—AKT1—epilepsy syndrome	4.45e-07	4.79e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—AKT1—epilepsy syndrome	3.81e-07	4.1e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.94e-07	3.16e-06	CbGpPWpGaD
